MENU
FHLC
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

FHLC stock forecast, quote, news & analysis

The investment seeks to provide investment returns that correspond, before fees and expenses, generally to the performance of the MSCI USA IMI Health Care 25/50 Index... Show more

Category: #Health
FHLC
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
A.I.Advisor
a Summary for FHLC with price predictions
Sep 11, 2026

FHLC in downward trend: price dove below 50-day moving average on September 10, 2026

FHLC moved below its 50-day moving average on September 10, 2026 date and that indicates a change from an upward trend to a downward trend. In 29 of 36 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 81%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for FHLC moved out of overbought territory on August 26, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In 24 of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at 73%.

The Momentum Indicator moved below the 0 level on September 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FHLC as a result. In 67 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 79%.

The Moving Average Convergence Divergence Histogram (MACD) for FHLC turned negative on August 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 34 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 77%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FHLC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +1.07% 3-day Advance, the price is estimated to grow further. Considering data from situations where FHLC advanced for three days, in 256 of 317 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

FHLC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 211 of 253 cases where FHLC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 83%.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), Unitedhealth Group (NYSE:UNH), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Intuitive Surgical (NASDAQ:ISRG).

Industry description

The investment seeks to provide investment returns that correspond, before fees and expenses, generally to the performance of the MSCI USA IMI Health Care 25/50 Index. The fund invests at least 80% of assets in securities included in the fund's underlying index. The fund's underlying index is the MSCI USA IMI Health Care 25/50 Index, which represents the performance of the health care sector in the U.S. equity market. It may or may not hold all of the securities in the MSCI USA IMI Health Care 25/50 Index. The fund is non-diversified.

Market Cap

The average market capitalization across the Fidelity MSCI Health Care ETF ETF is 21.62B. The market cap for tickers in the group ranges from 73.07M to 994.49B. LLY holds the highest valuation in this group at 994.49B. The lowest valued company is PLRX at 73.07M.

High and low price notable news

The average weekly price growth across all stocks in the Fidelity MSCI Health Care ETF ETF was -3%. For the same ETF, the average monthly price growth was -2%, and the average quarterly price growth was 13%. ROIV experienced the highest price growth at 17%, while RNA experienced the biggest fall at -27%.

Volume

The average weekly volume growth across all stocks in the Fidelity MSCI Health Care ETF ETF was 19%. For the same stocks of the ETF, the average monthly volume growth was -7% and the average quarterly volume growth was -36%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 63
Price Growth Rating: 46
SMR Rating: 78
Profit Risk Rating: 80
Seasonality Score: -22 (-100 ... +100)
View a ticker or compare two or three
FHLC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Details
Category
Health
Address
82 Devonshire StreetBoston
Phone
N/A
Web
www.institutional.fidelity.com